Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Immune checkpoint inhibitors (ICI) have drastically changed the landscape of metastatic melanoma management, thus significantly improving survival. Clinically, assessing treatment response may be challenging in a portion of cases due to a massive influx of immune cells into the tumor microenvironmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Diogo, Beal, Juliana Rodrigues, Alvarez, Daniel Mamere, Macarenco, Ricardo Silvestre e Silva, Schvartsman, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255661/
https://www.ncbi.nlm.nih.gov/pubmed/34248554
http://dx.doi.org/10.1159/000516036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255661/
https://www.ncbi.nlm.nih.gov/pubmed/34248554
http://dx.doi.org/10.1159/000516036

Ejemplares similares